Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program.

[1]  Michael Böhm,et al.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[2]  Naoki Sato,et al.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.

[3]  Robert O. Bonow,et al.  Rehospitalization for heart failure: problems and perspectives. , 2013, Journal of the American College of Cardiology.

[4]  J. McMurray,et al.  Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial , 2017, European journal of heart failure.

[5]  P. Ponikowski,et al.  Physicians' adherence to guideline‐recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey , 2016, European journal of heart failure.

[6]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[7]  Piotr Ponikowski,et al.  EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.

[8]  A. Bagriy,et al.  Addition of Ivabradine to β-Blocker Improves Exercise Capacity in Systolic Heart Failure Patients in a Prospective, Open-Label Study , 2015, Advances in Therapy.

[9]  K. Swedberg,et al.  Heart rate and its reduction in chronic heart failure and beyond , 2017, European journal of heart failure.

[10]  K. Swedberg,et al.  Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post‐hoc analysis of SHIFT , 2016, European journal of heart failure.

[11]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[12]  M. Cowie,et al.  The Optimize Heart Failure Care Program: Initial lessons from global implementation. , 2017, International journal of cardiology.

[13]  C. Siu,et al.  Heart failure across Asia: Same healthcare burden but differences in organization of care. , 2016, International journal of cardiology.

[14]  Jacob P. Kelly,et al.  Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs. , 2016, The American journal of cardiology.

[15]  K. Swedberg,et al.  Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. , 2011, European Heart Journal.

[16]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[17]  G. Fonarow,et al.  Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.

[18]  C. Zugck,et al.  Ivabradine Treatment in a Chronic Heart Failure Patient Cohort: Symptom Reduction and Improvement in Quality of Life in Clinical Practice , 2014, Advances in Therapy.

[19]  M. Gheorghiade,et al.  Timing and Duration of Interventions in Clinical Trials for Patients With Hospitalized Heart Failure , 2013, Circulation. Heart failure.

[20]  M. Pan,et al.  Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study. , 2016, International journal of cardiology.

[21]  P. Ponikowski,et al.  Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry , 2017, European journal of heart failure.

[22]  K. Swedberg,et al.  Risk following hospitalization in stable chronic systolic heart failure , 2013, European journal of heart failure.